United States
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 3.85 B
|
Sept. 30, 2024 | USD 164.41 | -1.15% |
|
United States |
|
2 |
USD 98.48 M
|
Sept. 30, 2024 | USD 16.32 | -1.03% |
|
United States |
|
3 |
USD 25.46 M
|
Sept. 30, 2024 | USD 12.48 | NA |
|
United States |
|
4 |
USD -10.19 M
|
Sept. 30, 2024 | USD 2.54 | -7.30% |
|
United States |
|
5 |
USD -13.37 M
|
July 31, 2024 | USD 2.13 | -2.74% |
|
United States |
|
6 |
USD -24.34 M
|
Sept. 30, 2024 | USD 2.11 | -0.47% |
|
United States |
|
7 |
USD -30.56 M
|
Sept. 30, 2024 | USD 5.96 | -8.87% |
|
United States |
|
8 |
USD -41.83 M
|
Sept. 30, 2024 | USD 1.86 | 4.49% |
|
United States |
|
9 |
USD -52.52 M
|
Sept. 30, 2024 | USD 4.69 | -4.29% |
|
United States |
|
10 |
USD -59.33 M
|
Sept. 30, 2024 | USD 16.59 | -4.16% |
|
United States |
|
11 |
USD -75.14 M
|
Sept. 30, 2024 | USD 3.18 | -5.08% |
|
United States |
|
12 |
USD -112.74 M
|
Sept. 30, 2024 | USD 9.38 | -6.57% |
|
United States |
|
13 |
USD -123.21 M
|
Sept. 30, 2024 | USD 12.31 | -23.96% |
|
United States |
|
14 |
USD -143.17 M
|
Sept. 30, 2024 | USD 1.97 | -1.50% |
|
United States |
|
15 |
USD -216.35 M
|
Sept. 30, 2024 | USD 8.51 | -1.16% |
|
United States |
|
16 |
USD -421.08 M
|
Sept. 30, 2024 | USD 2.32 | -6.45% |
|
United States |
|
17 |
USD -553.89 M
|
Sept. 30, 2024 | USD 10.23 | -2.76% |
|
United States |
|
18 |
USD -584.23 M
|
Sept. 30, 2024 | USD 78.14 | -3.73% |
|
United States |
|
19 |
USD -2.07 B
|
Sept. 30, 2024 | USD 34.46 | -1.96% |
|
United States |
The Vaccines company in United States with the highest EBITDA is Zoetis Inc. (NYSE: ZTS) at USD 3.85 B.
The Vaccines company in United States with the lowest EBITDA is Moderna, Inc. (NasdaqGS: MRNA) at USD -2.07 B.
The top 10 Vaccines companies in United States by EBITDA are Zoetis Inc., ADMA Biologics, Inc., Dynavax Technologies Corporation, Marker Therapeutics, Inc., Anixa Biosciences, Inc., GeoVax Labs, Inc., INmune Bio, Inc., HOOKIPA Pharma Inc., TriSalus Life Sciences, Inc. and Arcturus Therapeutics Holdings Inc..
The bottom 10 Vaccines companies in United States by EBITDA are Moderna, Inc., Vaxcyte, Inc., Vir Biotechnology, Inc., ImmunityBio, Inc., Novavax, Inc., HilleVax, Inc., Atara Biotherapeutics, Inc., Immunome, Inc., Arbutus Biopharma Corporation and Arcturus Therapeutics Holdings Inc..